ClinicalTrials.Veeva

Menu

Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing

Stanford University logo

Stanford University

Status

Terminated

Conditions

Cutaneous T-cell Lymphoma
Mycosis Fungoides
Cutaneous Lymphoma
Other Skin Disorders

Study type

Observational

Funder types

Other

Identifiers

NCT01556828
LYMNHL0091
21750 (Other Identifier)
SU-03142012-9329 (Other Identifier)

Details and patient eligibility

About

The goal of this study is to identify genetic changes associated with the initiation, progression, and treatment response of response of cutaneous and hematologic disorders using recently developed high-throughput sequencing technologies. The improved understanding of the genetic changes associated with cutaneous and hematologic disorders may lead to improved diagnostic, prognostic and therapeutic options for these disorders.

Enrollment

70 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age or older
  • Patient meets the clinical and/or pathologic criteria for the cutaneous or hematologic disorder being examined.
  • Patient is willing to provide skin biopsies and five 10 mL tubes of peripheral blood.

Exclusion criteria

  • Less than 18 years of age

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems